These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 22227046

  • 1. Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.
    Guaraldi G, Lonardo A, Ballestri S, Zona S, Stentarelli C, Orlando G, Carli F, Carulli L, Roverato A, Loria P.
    Arch Med Res; 2011 Nov; 42(8):690-7. PubMed ID: 22227046
    [Abstract] [Full Text] [Related]

  • 2. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P.
    Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
    [Abstract] [Full Text] [Related]

  • 3. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V, Puoti M, Mussini C, Bellelli S, Angeletti C, Sabbatini F, Prati F, Cossarizza A, Esposito R.
    Antivir Ther; 2008 Jul; 13(8):1057-65. PubMed ID: 19195331
    [Abstract] [Full Text] [Related]

  • 4. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G, Squillace N, Stentarelli C, Orlando G, D'Amico R, Ligabue G, Fiocchi F, Zona S, Loria P, Esposito R, Palella F.
    Clin Infect Dis; 2008 Jul 15; 47(2):250-7. PubMed ID: 18532884
    [Abstract] [Full Text] [Related]

  • 5. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
    Marks KM, Petrovic LM, Talal AH, Murray MP, Gulick RM, Glesby MJ.
    J Infect Dis; 2005 Dec 01; 192(11):1943-9. PubMed ID: 16267765
    [Abstract] [Full Text] [Related]

  • 6. [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].
    Lonardo A, Loria P, Adinolfi LE, Andreana A, Ruggiero G, Carulli N.
    Ann Ital Med Int; 2005 Dec 01; 20(1):10-22. PubMed ID: 15859390
    [Abstract] [Full Text] [Related]

  • 7. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S, Cammà C, Di Marco V, Cabibi D, Ciminnisi S, Caldarella R, Licata A, Massenti MF, Marchesini G, Craxì A.
    Antivir Ther; 2009 Dec 01; 14(5):631-9. PubMed ID: 19704165
    [Abstract] [Full Text] [Related]

  • 8. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J.
    Hepatology; 2006 Dec 01; 44(6):1648-55. PubMed ID: 17133473
    [Abstract] [Full Text] [Related]

  • 9. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P.
    Gastroenterology; 2008 Feb 01; 134(2):416-23. PubMed ID: 18164296
    [Abstract] [Full Text] [Related]

  • 10. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
    Petta S, Cammà C, Di Marco V, Alessi N, Barbaria F, Cabibi D, Caldarella R, Ciminnisi S, Licata A, Massenti MF, Mazzola A, Tarantino G, Marchesini G, Craxì A.
    Hepatology; 2008 Jul 01; 48(1):28-37. PubMed ID: 18506842
    [Abstract] [Full Text] [Related]

  • 11. Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.
    Machado MV, Oliveira AG, Cortez-Pinto H.
    Hepatology; 2010 Jul 01; 52(1):71-8. PubMed ID: 20578130
    [Abstract] [Full Text] [Related]

  • 12. High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.
    Berenguer J, Fernandez-Rodríguez A, Jimenez-Sousa MA, Cosín J, Zarate P, Micheloud D, López JC, Miralles P, Catalán P, Resino S.
    Cytokine; 2012 Jan 01; 57(1):25-9. PubMed ID: 22136974
    [Abstract] [Full Text] [Related]

  • 13. Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.
    Rodríguez-Torres M, Govindarajan S, Solá R, Clumeck N, Lissen E, Pessôa M, Buggisch P, Main J, Depamphilis J, Dieterich DT.
    J Hepatol; 2008 May 01; 48(5):756-64. PubMed ID: 18314217
    [Abstract] [Full Text] [Related]

  • 14. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME, Lima-Cabello E, Sánchez-Campos S, García-Mediavilla MV, Fernández-Bermejo M, Lozano-Rodríguez T, Vargas-Castrillón J, Buqué X, Ochoa B, Aspichueta P, González-Gallego J, García-Monzón C.
    Gut; 2011 Oct 01; 60(10):1394-402. PubMed ID: 21270117
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.
    Merchante N, Macías J, Ramayo E, Vergara S, García-García JA, Mira JA, Corzo JE, Gómez-Mateos JM, Lozano F, Pineda JA.
    J Viral Hepat; 2006 Jul 01; 13(7):449-56. PubMed ID: 16792538
    [Abstract] [Full Text] [Related]

  • 17. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection.
    Gaslightwala I, Bini EJ.
    J Hepatol; 2006 Jun 01; 44(6):1026-32. PubMed ID: 16618518
    [Abstract] [Full Text] [Related]

  • 18. Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection.
    Monto A, Dove LM, Bostrom A, Kakar S, Tien PC, Wright TL.
    Hepatology; 2005 Aug 01; 42(2):310-6. PubMed ID: 16025515
    [Abstract] [Full Text] [Related]

  • 19. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS.
    Am J Gastroenterol; 2003 Sep 01; 98(9):2064-71. PubMed ID: 14499789
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection.
    Dezzutti CS, Astemborski J, Thomas DL, Marshall JH, Cabrera T, Purdy M, Vlahov D, Garfein RS.
    J Clin Virol; 2004 Nov 01; 31(3):210-4. PubMed ID: 15465414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.